DuPont de Nemours reported third-quarter net sales of $1.868 billion and GAAP income from continuing operations of $171 million, exceeding guidance. Adjusted earnings per share reached $2.09, up 62% year-over-year, driven by mid-single-digit organic growth in Healthcare & Water Technologies and Diversified Industrials segments. The company raised its full-year 2026 adjusted EPS guidance to a range of $7.47–$7.52 per share, citing strong operating leverage and disciplined capital allocation. Additionally, DuPont announced an intent to repurchase $250 million of shares in the fourth quarter following the completion of $350 million in buybacks during Q3. The company operates as a global innovation leader providing advanced solutions for healthcare, water, construction, and industrial markets.
